Merck Sharp & Dohme Corp. et al. vs. Microspherix LLC
Explore the PTAB proceeding IPR2018-00602 filed by Merck Sharp & Dohme Corp. et al. on 2018-02-09. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-00602
Filing Date
2018-02-09
Accorded Filing Date
2018-02-09
Institution Decision Date
2018-07-23
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2019-07-08
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Merck Sharp & Dohme Corp. et al.
Represented By
Davies, Traceyet alPatent Owner / Respondent
Microspherix LLC
Represented By
Sernel, Marcet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 41074 | Robert Hodges | +1 404-879-2346 |
| 48731 | Rivka Monheit | +1 404-879-2152 |
| 61947 | Yvonne Shyntum | +1 404-879-2154 |
| 69007 | Adam Raymond | +1 404-879-2156 |
| 75574 | Austin Yongye | +1 404-879-2344 |
| 75683 | Carlos Zuniga | +1 404-879-2125 |
| 79352 | Tanyu Wang | +1 404-788-7517 |
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,821,835 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,636,401 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,636,402 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,493,181 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,994,058 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 24,912,800 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,746,661 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,514,193 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 41,205,002 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,776,310 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,470,294 B2 | US Continuation / Sibling | View Official Patent → |
Merck Sharp & Dohme Corp. et al. v. Microspherix LLC
MERCK SHARP & DOHME CORP. et al. v. Microspherix LLC
MERCK SHARP & DOHME CORP. et al. v. Microspherix LLC
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP β’ ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.